Cargando…

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome

BACKGROUND: Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited. METHODS: Bacterial community...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Marion, Endesfelder, David, Schloter-Hai, Brigitte, Kublik, Susanne, Granitsiotis, Michael S., Boschetto, Piera, Stendardo, Mariarita, Barta, Imre, Dome, Balazs, Deleuze, Jean-François, Boland, Anne, Müller-Quernheim, Joachim, Prasse, Antje, Welte, Tobias, Hohlfeld, Jens, Subramanian, Deepak, Parr, David, Gut, Ivo Glynne, Greulich, Timm, Koczulla, Andreas Rembert, Nowinski, Adam, Gorecka, Dorota, Singh, Dave, Gupta, Sumit, Brightling, Christopher E., Hoffmann, Harald, Frankenberger, Marion, Hofer, Thomas P., Burggraf, Dorothe, Heiss-Neumann, Marion, Ziegler-Heitbrock, Loems, Schloter, Michael, zu Castell, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509234/
https://www.ncbi.nlm.nih.gov/pubmed/28704452
http://dx.doi.org/10.1371/journal.pone.0180859
_version_ 1783249987396698112
author Engel, Marion
Endesfelder, David
Schloter-Hai, Brigitte
Kublik, Susanne
Granitsiotis, Michael S.
Boschetto, Piera
Stendardo, Mariarita
Barta, Imre
Dome, Balazs
Deleuze, Jean-François
Boland, Anne
Müller-Quernheim, Joachim
Prasse, Antje
Welte, Tobias
Hohlfeld, Jens
Subramanian, Deepak
Parr, David
Gut, Ivo Glynne
Greulich, Timm
Koczulla, Andreas Rembert
Nowinski, Adam
Gorecka, Dorota
Singh, Dave
Gupta, Sumit
Brightling, Christopher E.
Hoffmann, Harald
Frankenberger, Marion
Hofer, Thomas P.
Burggraf, Dorothe
Heiss-Neumann, Marion
Ziegler-Heitbrock, Loems
Schloter, Michael
zu Castell, Wolfgang
author_facet Engel, Marion
Endesfelder, David
Schloter-Hai, Brigitte
Kublik, Susanne
Granitsiotis, Michael S.
Boschetto, Piera
Stendardo, Mariarita
Barta, Imre
Dome, Balazs
Deleuze, Jean-François
Boland, Anne
Müller-Quernheim, Joachim
Prasse, Antje
Welte, Tobias
Hohlfeld, Jens
Subramanian, Deepak
Parr, David
Gut, Ivo Glynne
Greulich, Timm
Koczulla, Andreas Rembert
Nowinski, Adam
Gorecka, Dorota
Singh, Dave
Gupta, Sumit
Brightling, Christopher E.
Hoffmann, Harald
Frankenberger, Marion
Hofer, Thomas P.
Burggraf, Dorothe
Heiss-Neumann, Marion
Ziegler-Heitbrock, Loems
Schloter, Michael
zu Castell, Wolfgang
author_sort Engel, Marion
collection PubMed
description BACKGROUND: Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited. METHODS: Bacterial community composition derived from brush samples from lungs of 16 patients suffering from different CT defined subtypes of COPD and 9 healthy subjects was analyzed using a cultivation independent barcoding approach applying 454-pyrosequencing of 16S rRNA gene fragment amplicons. RESULTS: We could show that bacterial community composition in patients with changes in CT (either airway or emphysema type changes, designated as severe subtypes) was different from community composition in lungs of patients without visible changes in CT as well as from healthy subjects (designated as mild COPD subtype and control group) (PC1, P(adj) = 0.002). Higher abundance of Prevotella in samples from patients with mild COPD subtype and from controls and of Streptococcus in the severe subtype cases mainly contributed to the separation of bacterial communities of subjects. No significant effects of treatment with inhaled glucocorticoids on bacterial community composition were detected within COPD cases with and without abnormalities in CT in PCoA. Co-occurrence analysis suggests the presence of networks of co-occurring bacteria. Four communities of positively correlated bacteria were revealed. The microbial communities can clearly be distinguished by their associations with the CT defined disease phenotype. CONCLUSION: Our findings indicate that CT detectable structural changes in the lung of COPD patients, which we termed severe subtypes, are associated with alterations in bacterial communities, which may induce further changes in the interaction between microbes and host cells. This might result in a changed interplay with the host immune system.
format Online
Article
Text
id pubmed-5509234
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55092342017-08-07 Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome Engel, Marion Endesfelder, David Schloter-Hai, Brigitte Kublik, Susanne Granitsiotis, Michael S. Boschetto, Piera Stendardo, Mariarita Barta, Imre Dome, Balazs Deleuze, Jean-François Boland, Anne Müller-Quernheim, Joachim Prasse, Antje Welte, Tobias Hohlfeld, Jens Subramanian, Deepak Parr, David Gut, Ivo Glynne Greulich, Timm Koczulla, Andreas Rembert Nowinski, Adam Gorecka, Dorota Singh, Dave Gupta, Sumit Brightling, Christopher E. Hoffmann, Harald Frankenberger, Marion Hofer, Thomas P. Burggraf, Dorothe Heiss-Neumann, Marion Ziegler-Heitbrock, Loems Schloter, Michael zu Castell, Wolfgang PLoS One Research Article BACKGROUND: Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited. METHODS: Bacterial community composition derived from brush samples from lungs of 16 patients suffering from different CT defined subtypes of COPD and 9 healthy subjects was analyzed using a cultivation independent barcoding approach applying 454-pyrosequencing of 16S rRNA gene fragment amplicons. RESULTS: We could show that bacterial community composition in patients with changes in CT (either airway or emphysema type changes, designated as severe subtypes) was different from community composition in lungs of patients without visible changes in CT as well as from healthy subjects (designated as mild COPD subtype and control group) (PC1, P(adj) = 0.002). Higher abundance of Prevotella in samples from patients with mild COPD subtype and from controls and of Streptococcus in the severe subtype cases mainly contributed to the separation of bacterial communities of subjects. No significant effects of treatment with inhaled glucocorticoids on bacterial community composition were detected within COPD cases with and without abnormalities in CT in PCoA. Co-occurrence analysis suggests the presence of networks of co-occurring bacteria. Four communities of positively correlated bacteria were revealed. The microbial communities can clearly be distinguished by their associations with the CT defined disease phenotype. CONCLUSION: Our findings indicate that CT detectable structural changes in the lung of COPD patients, which we termed severe subtypes, are associated with alterations in bacterial communities, which may induce further changes in the interaction between microbes and host cells. This might result in a changed interplay with the host immune system. Public Library of Science 2017-07-13 /pmc/articles/PMC5509234/ /pubmed/28704452 http://dx.doi.org/10.1371/journal.pone.0180859 Text en © 2017 Engel et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Engel, Marion
Endesfelder, David
Schloter-Hai, Brigitte
Kublik, Susanne
Granitsiotis, Michael S.
Boschetto, Piera
Stendardo, Mariarita
Barta, Imre
Dome, Balazs
Deleuze, Jean-François
Boland, Anne
Müller-Quernheim, Joachim
Prasse, Antje
Welte, Tobias
Hohlfeld, Jens
Subramanian, Deepak
Parr, David
Gut, Ivo Glynne
Greulich, Timm
Koczulla, Andreas Rembert
Nowinski, Adam
Gorecka, Dorota
Singh, Dave
Gupta, Sumit
Brightling, Christopher E.
Hoffmann, Harald
Frankenberger, Marion
Hofer, Thomas P.
Burggraf, Dorothe
Heiss-Neumann, Marion
Ziegler-Heitbrock, Loems
Schloter, Michael
zu Castell, Wolfgang
Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title_full Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title_fullStr Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title_full_unstemmed Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title_short Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
title_sort influence of lung ct changes in chronic obstructive pulmonary disease (copd) on the human lung microbiome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509234/
https://www.ncbi.nlm.nih.gov/pubmed/28704452
http://dx.doi.org/10.1371/journal.pone.0180859
work_keys_str_mv AT engelmarion influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT endesfelderdavid influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT schloterhaibrigitte influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT kubliksusanne influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT granitsiotismichaels influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT boschettopiera influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT stendardomariarita influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT bartaimre influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT domebalazs influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT deleuzejeanfrancois influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT bolandanne influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT mullerquernheimjoachim influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT prasseantje influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT weltetobias influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT hohlfeldjens influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT subramaniandeepak influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT parrdavid influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT gutivoglynne influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT greulichtimm influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT koczullaandreasrembert influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT nowinskiadam influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT goreckadorota influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT singhdave influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT guptasumit influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT brightlingchristophere influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT hoffmannharald influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT frankenbergermarion influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT hoferthomasp influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT burggrafdorothe influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT heissneumannmarion influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT zieglerheitbrockloems influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT schlotermichael influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome
AT zucastellwolfgang influenceoflungctchangesinchronicobstructivepulmonarydiseasecopdonthehumanlungmicrobiome